Retroperitoneal fibrosis after chemotherapy.

Abstract

We report the case of a patient with a non-Hodgkin lymphoma, who after a standard chemotherapy protocol, developed retroperitoneal fibrosis (RPF) in the absence of radiotherapy or other known causes. The final diagnosis was reached with the microscopic examination of tissue obtained by fine-needle aspiration and true-cut biopsy of the retroperitoneal mass. RPF can be related to chemotherapy alone.

• Authors: Ambrogio Fassina, Rafael Boscolo Berto, Rafi El Mazloum, Fedra Gottardo, Walter Artibani
• Journal: European urology (Eur Urol) Vol. 51 Issue 1 Pg. 270-1; quiz 272 (Jan 2007) ISSN: 0302-2838 [Print] Switzerland
• PMID: 16632190 (Publication Type: Case Reports, Journal Article)

Chemical References

• Cytarabine
• Bleomycin
• Vincristine
• Etoposide
• Doxorubicin
• Cyclophosphamide
• Prednisone
• Methotrexate

Topics

• Aged
• Antineoplastic Combined Chemotherapy Protocols (adverse effects)
• Bleomycin (adverse effects)
• Cyclophosphamide (adverse effects)
• Cytarabine (adverse effects)
• Doxorubicin (adverse effects)
• Etoposide (adverse effects)
• Female
• Humans
• Lymphoma, Non-Hodgkin (drug therapy)
• Methotrexate (adverse effects)
• Prednisone (adverse effects)
• Retroperitoneal Fibrosis (chemically induced)
• Retroperitoneal Neoplasms (drug therapy)
• Vincristine (adverse effects)